Medicamen Organics, which manufactures, and distributes pharmaceutical dosages, launched its initial public offerings (IPO) on June 21. The small and medium enterprise (SME) was subscribed over 40.25 times on the first day of subscription. The issue has allocated 584,000 shares (18.84%) to Qualified Institutional Buyers (QIB), 440,000 shares (14.19%) to […]